Staburo At The PSI Conference 2025

From June 8th to 11th, 2025, Staburo was excited to participate in the highly anticipated PSI Annual Conference, held in Wembley, London. This event, considered one of the most important gatherings in the pharmaceutical and healthcare sectors, brought together a diverse community of professionals of this industry. With its focus on innovation and cutting-edge advancements in drug development and precision medicine, the conference provided an invaluable platform for sharing knowledge, fostering collaboration, and exploring the future of healthcare. 

Among the many highlights of the event was the presentation of a poster titled “Machine Learning in Precision Medicine: A Collaborative Approach.” This work was the result of a concerted effort by the Machine Learning workstream of the PSI Biomarker European Special Interest Group (ESIG), with Staburo’s Director Biostatistics Focus Area Biomarker, Laura Schlieker playing a central role in the presentation. The poster sparked engaging discussions on how machine learning technologies can be integrated into biomarker-driven strategies to accelerate the development of personalized treatments. The presentation was met with great enthusiasm and was honoured with one of the four Best Poster awards, recognizing the significance of the work in advancing the field. 

The conference also served as a valuable opportunity for the members of the Biomarker ESIG to come together in person, strengthening existing partnerships and opening the door to new collaborations. 

At Staburo, we are deeply committed to advancing innovative research that bridges the gap between machine learning and biomarker-driven approaches. Our participation in the PSI Annual Conference as well as the Biomarkers ESIG underscores our ongoing efforts to be at the forefront of scientific discovery and to collaborate with like-minded experts in the pursuit of better, more tailored healthcare solutions. 

Business Unit Team Event 2025

Our business unit (as we call our corporate functions team—bringing HR, Finance, IT, Business Development, Quality and Office Management under one unified vision) gathered recently for a flavourful evening of fun, food, and fantastic company at Eataly in Munich and what a night it was! 

After leaving the office, we kicked off the evening with a warm welcome of drinks, and delicious appetizers. The main highlight? A hands-on pasta cooking class, where we rolled up our sleeves and tied on our aprons to make fresh Tagliatelle from scratch. 

With some Italian spirit and fantastic teamwork, we succeeded in creating some truly impressive pasta. Followed, of course, by a well-earned dinner featuring our own homemade creations, paired with wine and topped off with a sweet dessert to finish the night. 

From laughter in the kitchen to great conversations around the table, the event was a wonderful opportunity to connect outside of our usual work setting and strengthen our team spirit. 

A huge thank you to everyone who joined and helped make the evening such a success. 

Here’s to more great moments together both in and out of the office! 

Staburo At ICH E6 (R3) Training 

We were delighted to welcome two highly experienced trainers, Dr. Andreas Berk and Helge Bonaventura from InnovationTriologie, to our Munich office for an engaging hybrid training session on the updated ICH E6 (R3) guideline. The training offered a comprehensive look at both GCP basic principles and the key changes from ICH E6 (R2) to the new R3 version, making it valuable for colleagues at all levels of experience. 

The friendly and open atmosphere encouraged participants to ask interesting questions and share their perspectives, enriching the learning experience for everyone. 

A coffee break offered the chance to network and reflect on the morning’s content, and we enjoyed a relaxed lunch afterwards with the trainers, providing further opportunity for exchange in an informal setting. 

We would like to thank Dr. Andreas Berk and Helge Bonaventura for their expert guidance and Q&A opportunity after the session, and all attendees for their active participation.  

At Staburo, we prioritise maintaining awareness of evolving regulatory requirements, as they form a fundamental part of our commitment to quality and excellence in clinical research. 

Staburo welcomes its 100th employee

We’re proud to announce an important milestone in our company’s journey. Staburo GmbH has officially grown to a team of over 100 professionals! This achievement is more than just a number — it reflects our ongoing commitment to delivering high-quality health data science solutions.

From our early days, we are a trusted partner for pharmaceutical, CRO, and biotech companies.

This milestone is a testament to the impact of our team’s work and the strength of the collaborations we’ve built over the years.

We are incredibly thankful to our clients who have placed their trust in us, and to every team member who has helped shape Staburo into what it is today.

As we look toward the future, we remain committed our core purpose: Excellent data science to save and improve lives

Staburo Walk & Run Event 2025

This May, we came together once again for our annual Run & Walk event — a long-standing tradition that brings colleagues outside the office to connect, recharge, and share time together in a different setting.

We left the office in the afternoon and met near the Tierpark entrance. The atmosphere was filled with anticipation and connection as colleagues prepared for a 3 km walk or a 6 km run, following a group warm-up. The setting, the movement, and the shared experience made it a truly enjoyable afternoon.

We were especially pleased to welcome several remote colleagues who travelled in to join us in person, adding to the sense of unity and making the occasion even more meaningful.

After the activity, the teams regrouped for a fun quiz session. Formed on the spot, the teams competed in rounds of light-hearted trivia — a great way to continue the energy and teamwork in a more relaxed format. Congratulations to the winning team and thank you to all who took part.

The event concluded with a casual picnic by the Isar “beach,” with food and drinks from La Tarti, plenty of conversation, and even a few spontaneous games of volleyball. It was the perfect way to round off the day.

A big thank you to everyone who participated, whether from nearby or further away. Special appreciation goes to the organizing team for making the day seamless. It was a true celebration of team spirit and shared experience — and we look forward to more moments like this in the future.

Staburo @ EMWA Webinar 2025

Inspired by the internal Estimand Strategic Initiatives Working Group—and through many fruitful discussions with biostatisticians, disclosure managers, and medical writers, our Senior Disclosure Manager and Medical Writer, Ulrike Fischer has come to appreciate just how essential estimands are across the medical writing landscape.

The Estimand Strategic Initiatives Working Group, which ran for over a year, explored how the ICH E9(R1) estimand framework influences key clinical development documents, including clinical study protocols, statistical analysis plans, clinical study reports, and disclosure activities. The group examined how endpoints and intercurrent events are handled differently depending on the study phase or indication—whether in oncology, infectious diseases, or diabetes—and learned from colleagues engaged in wider industry initiatives, such as the “Reporting of Estimands” subgroup of the Estimand Implementation Working Group (EIWG) at EFPIA.

In parallel, as an active member of the European Medical Writers Association (EMWA), Ulrike presented a poster at the recent EMWA Spring Conference in Valencia: “An Attempt to Translate Estimands into Plain Language.”
The poster aimed to bridge the gap between complex estimand concepts and clear, accessible communication. Through conversations at the conference and on LinkedIn, Ulrike found that while many medical writers are familiar with the estimand framework in theory, relatively few have applied it in practice. It became evident that, so far, estimands have only marginally entered the day-to-day world of medical writing.

Recognising that medical writers serve as connectors across disciplines, Ulrike emphasizes that developing a strong understanding of estimands enhances how clinical documents are authored, reviewed, and structured—bringing greater clarity and scientific rigor to the work.

Another highlight of the year was hosting the webinar “Estimands in Protocols” for the EMWA Regulatory Writing Special Interest Group in April.
Over 100 medical writers from around the world participated, contributing to lively, thought-provoking discussions and providing encouraging feedback. She is grateful to her colleagues, the EMWA community, and the inspiring co-leaders who helped make the webinar such a success.

Looking Ahead: EMWA Spring Conference 2025
Ulrike is excited to participate in the upcoming EMWA Spring Conference this May in Riga. She is looking forward to connecting with colleagues and continuing the conversation about estimands and the evolving role of medical writing.